HRP20070183A2 - Use of androgens to reduce the likelihood of acquiring or to treat skin aging - Google Patents
Use of androgens to reduce the likelihood of acquiring or to treat skin agingInfo
- Publication number
- HRP20070183A2 HRP20070183A2 HR20070183A HRP20070183A HRP20070183A2 HR P20070183 A2 HRP20070183 A2 HR P20070183A2 HR 20070183 A HR20070183 A HR 20070183A HR P20070183 A HRP20070183 A HR P20070183A HR P20070183 A2 HRP20070183 A2 HR P20070183A2
- Authority
- HR
- Croatia
- Prior art keywords
- likelihood
- acquiring
- loss
- androgens
- reduce
- Prior art date
Links
- 239000003098 androgen Substances 0.000 title abstract 3
- 229940030486 androgens Drugs 0.000 title 1
- 230000009759 skin aging Effects 0.000 title 1
- 208000035484 Cellulite Diseases 0.000 abstract 1
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010049752 Peau d'orange Diseases 0.000 abstract 1
- 206010040799 Skin atrophy Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000036232 cellulite Effects 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 210000002808 connective tissue Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000004177 elastic tissue Anatomy 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 230000037373 wrinkle formation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62411204P | 2004-11-01 | 2004-11-01 | |
| PCT/CA2005/001652 WO2006047859A1 (en) | 2004-11-01 | 2005-10-31 | Use of androgens to reduce the likelihood of acquiring or to treat skin aging |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20070183A2 true HRP20070183A2 (en) | 2007-08-31 |
Family
ID=36318842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20070183A HRP20070183A2 (en) | 2004-11-01 | 2007-04-30 | Use of androgens to reduce the likelihood of acquiring or to treat skin aging |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20060178352A1 (ru) |
| EP (1) | EP1807062A4 (ru) |
| JP (1) | JP2008517952A (ru) |
| KR (1) | KR20070073964A (ru) |
| CN (1) | CN101094676A (ru) |
| AP (1) | AP2007003982A0 (ru) |
| AU (1) | AU2005301035A1 (ru) |
| BR (1) | BRPI0517950A (ru) |
| CA (1) | CA2585666A1 (ru) |
| EA (1) | EA200700983A1 (ru) |
| GE (1) | GEP20094833B (ru) |
| HR (1) | HRP20070183A2 (ru) |
| IL (1) | IL182844A0 (ru) |
| MA (1) | MA29220B1 (ru) |
| MX (1) | MX2007005098A (ru) |
| NO (1) | NO20072642L (ru) |
| RS (1) | RS20070185A (ru) |
| TN (1) | TNSN07163A1 (ru) |
| WO (1) | WO2006047859A1 (ru) |
| ZA (1) | ZA200703531B (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006042409A1 (en) | 2004-10-20 | 2006-04-27 | Endorecherche, Inc. | Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women |
| CN101461294B (zh) | 2006-06-01 | 2011-05-18 | 松下电器产业株式会社 | 洗衣机用无刷电动机以及搭载其的洗衣机 |
| US8268806B2 (en) | 2007-08-10 | 2012-09-18 | Endorecherche, Inc. | Pharmaceutical compositions |
| WO2015055179A1 (de) * | 2013-10-15 | 2015-04-23 | Chelac Holding Gmbh | Steroid-carbonsäureester, zusammensetzungen, enthaltend steroid-carbonsäureester und verwendung dieser bei lokal topischer applikation für kosmetische oder dermatologische zwecke |
| CN107949389A (zh) * | 2015-09-30 | 2018-04-20 | 富士胶片株式会社 | 经皮吸收用组合物 |
| US20220339176A1 (en) * | 2019-09-23 | 2022-10-27 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of Treatments to Prolong Gestation and Complications of Menstruation or Gestation |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL190146A (ru) * | 1953-08-26 | |||
| NZ512334A (en) * | 1993-01-19 | 2005-05-27 | Endorech Inc | Therapeutic methods and delivery systems utilizing sex steroid precursors |
| FR2729854A1 (fr) * | 1995-01-26 | 1996-08-02 | Oreal | Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique |
| US5736537A (en) * | 1995-09-12 | 1998-04-07 | Estee Lauder, Inc. | Dehydroep:androsterone sailcylate useful against skin atrophy |
| US5709878A (en) * | 1996-08-02 | 1998-01-20 | Rosenbaum; Jerry | Transdermal delivery of dehydroepiandrosterone |
| US5869090A (en) * | 1998-01-20 | 1999-02-09 | Rosenbaum; Jerry | Transdermal delivery of dehydroepiandrosterone |
| CN1879630A (zh) * | 1998-06-11 | 2006-12-20 | 内部研究股份有限公司 | 雄－5－烯－3β,17β－二醇的药物组合物及其用途 |
| US6117446A (en) * | 1999-01-26 | 2000-09-12 | Place; Virgil A. | Drug dosage unit for buccal administration of steroidal active agents |
| FR2803750B1 (fr) * | 2000-01-17 | 2004-04-02 | Assist Publ Hopitaux De Paris | Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant |
| US20040198706A1 (en) * | 2003-03-11 | 2004-10-07 | Carrara Dario Norberto R. | Methods and formulations for transdermal or transmucosal application of active agents |
| US20030027804A1 (en) * | 2001-06-27 | 2003-02-06 | Van Der Hoop Roland Gerritsen | Therapeutic combinations for the treatment of hormone deficiencies |
| JP2004002321A (ja) * | 2002-03-11 | 2004-01-08 | Takeda Chem Ind Ltd | 性ホルモン依存性疾患治療剤 |
| IL157535A0 (en) * | 2003-08-21 | 2004-03-28 | Topimed Ltd | Preparations for the prevention of skin atrophy |
-
2005
- 2005-10-31 JP JP2007538225A patent/JP2008517952A/ja active Pending
- 2005-10-31 AU AU2005301035A patent/AU2005301035A1/en not_active Abandoned
- 2005-10-31 MX MX2007005098A patent/MX2007005098A/es not_active Application Discontinuation
- 2005-10-31 CN CNA2005800456687A patent/CN101094676A/zh active Pending
- 2005-10-31 EA EA200700983A patent/EA200700983A1/ru unknown
- 2005-10-31 GE GEAP200510104A patent/GEP20094833B/en unknown
- 2005-10-31 AP AP2007003982A patent/AP2007003982A0/xx unknown
- 2005-10-31 BR BRPI0517950-5A patent/BRPI0517950A/pt not_active IP Right Cessation
- 2005-10-31 EP EP05799216A patent/EP1807062A4/en not_active Withdrawn
- 2005-10-31 KR KR1020077012537A patent/KR20070073964A/ko not_active Application Discontinuation
- 2005-10-31 RS RSP-2007/0185A patent/RS20070185A/sr unknown
- 2005-10-31 WO PCT/CA2005/001652 patent/WO2006047859A1/en active Application Filing
- 2005-10-31 CA CA002585666A patent/CA2585666A1/en not_active Abandoned
- 2005-11-01 US US11/264,704 patent/US20060178352A1/en not_active Abandoned
-
2007
- 2007-04-27 TN TNP2007000163A patent/TNSN07163A1/fr unknown
- 2007-04-29 IL IL182844A patent/IL182844A0/en unknown
- 2007-04-30 ZA ZA200703531A patent/ZA200703531B/xx unknown
- 2007-04-30 HR HR20070183A patent/HRP20070183A2/xx not_active Application Discontinuation
- 2007-05-23 NO NO20072642A patent/NO20072642L/no not_active Application Discontinuation
- 2007-05-30 MA MA29957A patent/MA29220B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2585666A1 (en) | 2006-05-11 |
| MX2007005098A (es) | 2008-01-16 |
| EP1807062A4 (en) | 2009-06-03 |
| EP1807062A1 (en) | 2007-07-18 |
| TNSN07163A1 (en) | 2008-11-21 |
| US20060178352A1 (en) | 2006-08-10 |
| WO2006047859A1 (en) | 2006-05-11 |
| MA29220B1 (fr) | 2008-02-01 |
| AU2005301035A1 (en) | 2006-05-11 |
| BRPI0517950A (pt) | 2008-10-21 |
| ZA200703531B (en) | 2008-07-30 |
| RS20070185A (en) | 2008-09-29 |
| GEP20094833B (en) | 2009-11-25 |
| EA200700983A1 (ru) | 2008-04-28 |
| JP2008517952A (ja) | 2008-05-29 |
| KR20070073964A (ko) | 2007-07-10 |
| AP2007003982A0 (en) | 2007-06-30 |
| IL182844A0 (en) | 2007-09-20 |
| NO20072642L (no) | 2007-07-30 |
| CN101094676A (zh) | 2007-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| HRP20070183A2 (en) | Use of androgens to reduce the likelihood of acquiring or to treat skin aging | |
| TW200509956A (en) | Compositions and methods for treatment of rosacea | |
| ATE269113T1 (de) | Sprühfähige wundversorgungszusammensetzung | |
| WO2006073786A3 (en) | Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy | |
| WO2005105107A3 (en) | Hormone treatment of multiple sclerosis | |
| BR0317747A (pt) | Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave | |
| AR049518A1 (es) | Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados | |
| ATE500817T1 (de) | Schäumbare zusammensetzung, die im wesentlichen frei von pharmazeutisch aktiven inhaltsstoffen ist, zur behandlung der menschlichen haut | |
| ATE500855T1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| EA200870393A1 (ru) | Новые композиции для нарушений волос и способ получения композиций | |
| MX2011010781A (es) | Una crema medicinal hecha con sulfadiazina de plata y quitosano y un proceso para hacerla. | |
| ATE333885T1 (de) | Verwendung von sulodexid zur behandlung von reizdarm | |
| ATE550015T1 (de) | Verfahren und zusammensetzung zur behandlung von rhinitis | |
| MX2010009623A (es) | Derivados de 1-bencil-3-hidroximetilindazol novedosos y su uso en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40. | |
| MX2010009625A (es) | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40. | |
| WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
| MX2010009624A (es) | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1. | |
| HK1112721A1 (en) | Tissue disruption treatment and composition for use thereof | |
| BRPI0415756A (pt) | lipólise medicamentosa local, dirigida | |
| WO2007029188A3 (en) | Method of using fabric care compositions to achieve a synergistic odor benefit | |
| DE60330888D1 (de) | Verwendung von drospirenon zur behandlung von hypertension | |
| EA201591793A1 (ru) | Лактамные соединения в качестве селективных агонистов ep4-рецепторов для применения при лечении опосредованных ep4 заболеваний и состояний | |
| WO2010119366A3 (en) | A medicinal cream made using fluticasone propionate, and chitosan, and a process to make the same | |
| WO2009106715A3 (fr) | Peptide derive d'une proteine de la famille des aquaporines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20091014 Year of fee payment: 5 |
|
| OBST | Application withdrawn |